Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective

Walter, Franziska; Cloughesy, Timothy; Walter, Martin A; Lai, Albert; Nghiemphu, Phioanh; Wagle, Naveed; Fueger, Barbara; Satyamurthy, Nagichettiar; Phelps, Michael E; Czernin, Johannes (2012). Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective. Journal of nuclear medicine, 53(3), pp. 393-8. New York, N.Y.: Society of Nuclear Medicine 10.2967/jnumed.111.095711

Full text not available from this repository. (Request a copy)

We investigated the impact of (18)F-DOPA brain PET/CT on the clinical management of patients with known or suspected brain tumors.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Walter, Martin Alexander

ISSN:

0161-5505

Publisher:

Society of Nuclear Medicine

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:35

Last Modified:

17 Mar 2015 21:25

Publisher DOI:

10.2967/jnumed.111.095711

PubMed ID:

22323780

Web of Science ID:

000301194300035

URI:

https://boris.unibe.ch/id/eprint/14250 (FactScience: 221123)

Actions (login required)

Edit item Edit item
Provide Feedback